Bruker (BRKRP) Current Deferred Revenue (2010 - 2026)

Bruker has reported Current Deferred Revenue for 17 years, with the latest figure at $586.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 24.54% year-over-year to $586.1 million; the trailing twelve-month figure through Mar 2026 stood at $586.1 million (up 24.54% YoY), and the FY2025 full-year result was $441.3 million, up 0.71% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $586.1 million, up from $441.3 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $595.8 million in Q2 2024, with the low at $175.5 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $440.6 million across 5 years, with a median of $441.3 million in 2025.
• The largest YoY upside for Current Deferred Revenue was 138.84% in 2022 against a maximum downside of 47.31% in 2022.
• Bruker's Current Deferred Revenue stood at $471.7 million in 2022, then retreated by 15.2% to $400.0 million in 2023, then gained by 9.55% to $438.2 million in 2024, then climbed by 0.71% to $441.3 million in 2025, then jumped by 32.81% to $586.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $586.1 million (Q1 2026), $441.3 million (Q4 2025), and $455.4 million (Q3 2025), per Business Quant data.